Clinical Trials Directory

Trials / Unknown

UnknownNCT02961296

Helicobacter Pylori Antibiotic Susceptibility Testing of Korea

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
19 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to make nationwide registry for antimicrobial resistance of Helicobacter pylori using single method with agar dilution in Korea.

Detailed description

Backgrounds: The success rate of Helicobacter pylori eradication in Korea is not sufficient in recent days. The main cause of eradication failure is known as antimicrobial resistance and previous studies showed that resistant rates were different according to the regions in Korea. However, until now, there are not enough studies about the nationwide results for antimicrobial resistance and previous reports used various methods for the resistant test. Theories and Plans: The nationwide resistant registry of Helicobacter pylori using standardized single method, agar dilution test, can be useful for the development of new eradication methods to make eradication rate higher. Moreover, the higher rate of Helicobacter pylori eradication can reduce the chance of gastric cancer and also can reduce the medical expenses.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention will be needed.

Timeline

Start date
2016-10-01
Primary completion
2017-12-01
Completion
2018-12-01
First posted
2016-11-10
Last updated
2016-11-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02961296. Inclusion in this directory is not an endorsement.